Correlation Between Bats Series and Biotechnology Ultrasector

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bats Series and Biotechnology Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bats Series and Biotechnology Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bats Series C and Biotechnology Ultrasector Profund, you can compare the effects of market volatilities on Bats Series and Biotechnology Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bats Series with a short position of Biotechnology Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bats Series and Biotechnology Ultrasector.

Diversification Opportunities for Bats Series and Biotechnology Ultrasector

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Bats and Biotechnology is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Bats Series C and Biotechnology Ultrasector Prof in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Ultrasector and Bats Series is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bats Series C are associated (or correlated) with Biotechnology Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Ultrasector has no effect on the direction of Bats Series i.e., Bats Series and Biotechnology Ultrasector go up and down completely randomly.

Pair Corralation between Bats Series and Biotechnology Ultrasector

Assuming the 90 days horizon Bats Series C is expected to generate 0.15 times more return on investment than Biotechnology Ultrasector. However, Bats Series C is 6.77 times less risky than Biotechnology Ultrasector. It trades about 0.1 of its potential returns per unit of risk. Biotechnology Ultrasector Profund is currently generating about -0.07 per unit of risk. If you would invest  881.00  in Bats Series C on December 30, 2024 and sell it today you would earn a total of  17.00  from holding Bats Series C or generate 1.93% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Bats Series C  vs.  Biotechnology Ultrasector Prof

 Performance 
       Timeline  
Bats Series C 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Bats Series C are ranked lower than 7 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong fundamental indicators, Bats Series is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Biotechnology Ultrasector 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Biotechnology Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Bats Series and Biotechnology Ultrasector Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bats Series and Biotechnology Ultrasector

The main advantage of trading using opposite Bats Series and Biotechnology Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bats Series position performs unexpectedly, Biotechnology Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Ultrasector will offset losses from the drop in Biotechnology Ultrasector's long position.
The idea behind Bats Series C and Biotechnology Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Transaction History
View history of all your transactions and understand their impact on performance